The company resolved to dissolve and liquidate the specified subsidiary Dewey Co., Ltd. As a business restructuring, the real estate management business will be terminated, and liquidation is expected to be completed in late December 2026. The impact on consolidated results is expected to be minor, but any new material developments will be disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3750","jir_company_name":"ADR Biomedical Holdings Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3750-20260930-01.pdf","jir_short_summary":"The company resolved to dissolve and liquidate the specified subsidiary Dewey Co., Ltd. As a business restructuring, the real estate management business will be terminated, and liquidation is expected to be completed in late December 2026. The impact on consolidated results is expected to be minor, but any new material developments will be disclosed.","jir_summary":"### Overview of the Dissolution\nThe Board of Directors resolved to dissolve and liquidate the specified subsidiary Dewey Co., Ltd. The business engages in real estate sales and management. The Group is concentrating management resources on its medical business, and the decision was made considering changes in the business environment and future profitability. It is stated that the company is 100% owned by the parent, and capital relationships, personnel relationships, and transaction relationships are specified.\n\n### Outlook and Impact\nThe schedule for dissolution and liquidation is as follows: the dissolution resolution date is September 30, 2026, and the expected liquidation completion date is late December 2026 (expected). Procedures will be carried out in accordance with applicable laws and regulations. The Company expects the impact on consolidated results to be minor, and there are no revisions to the consolidated earnings guidance for the fiscal year ending March 2027. If any matters that would have a material impact on performance are identified, they will be disclosed promptly.","jir_financial_highlights":"Impact on consolidated results: Unknown (Unknown)\nExpected liquidation completion date: Late December 2026 (expected) (Unknown)","jir_category":"","jir_hashtags":"#ADRBiomedicalHoldingsInc_none, #DissolutionOfSpecifiedSubsidiary, #OrganizationalRestructuring","jir_key_figures":"Dissolution resolution date: 2026-09-30\nExpected liquidation completion date: Late December 2026 (expected)\nCapital relationship: Parent company 100% ownership","jir_meta_title":"ADR Biomedical Holdings Inc. Decides to Dissolve and Liquidate Specified Subsidiary Dewey Co., Ltd.","jir_meta_description":"ADR Biomedical Holdings Inc. announced the dissolution and liquidation of its specified subsidiary Dewey Co., Ltd. The dissolution is due to termination of the real estate business and concentration of management resources on the medical business. Liquidation is expected to be completed in late December 2026. The company expects only a minor impact on consolidated results.","jir_og_title":"ADR Biomedical Holdings Inc. Decides to Dissolve and Liquidate Dewey Co., Ltd.","jir_og_description":"ADR Biomedical Holdings Inc. announced the dissolution and liquidation of its specified subsidiary Dewey Co., Ltd. The company expects minimal impact and plans to complete liquidation in late December 2026.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59367,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-125017","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n